Shin akwai wani amfana da amfani da Flonase da Astelin tare da rashin lafiya?
Duk da yake ba a samu bayanai mai yawa a kan wannan batu, nazarin ya nuna cewa yana da amfani wajen amfani da waɗannan magunguna guda biyu. Akwai magunguna da yawa don maganin rashin lafiyar rhinitis , ciki har da kwayoyin steroid , ƙananan antihistamines , maganin antihistamines da kuma Singulair . Yayin da mutane daban-daban suka sami nauyin maganin rashin lafiyar su tare da wadannan magunguna, an yarda da cewa kwayoyin steroid sune kwayar magani mafi mahimmanci don maganin rashin lafiyar rhinitis.
Duk da haka, ba kowane mutum ya kammala maganin rashin lafiyar jiki ba tare da magani daya. Abin takaici, akwai iyakanceccen bayanan da aka samo a kan ko yin amfani da magungunan maganin ƙwayar cuta guda biyu na ƙara ƙarin ƙarin amfani ga yin amfani da maganin likita daya.
Darasi biyu, wanda aka buga a shekara ta 2008 kuma ɗayan a shekarar 2010, ya nuna cewa amfani da Flonase (fluticasone propionate) tare da Astelin (azelastine) ya haifar da karin alamun alamun rashin lafiyar fiye da magani kawai. Ƙarin amfani ba ƙananan ba - haɗin Flonase da Astelin sun haifar da kimanin kashi 40 cikin haɓakar rashin lafiyar jiki idan aka kwatanta da ko dai magani kawai. Wannan cigaba ba wai kawai ya shafi ƙwayoyin cututtuka ba, amma ga magungunan ido . Abin sha'awa shine, binciken na 2010 ya haɗa da yin amfani da na'urar samar da ƙwayar ƙwayar guda daya don kulawa da magunguna - yana nuna cewa samfurin guda daya dauke da magunguna zai iya samuwa a nan gaba.
Ƙara koyo game da amfani da samfurori na hanci domin maganin allergies .
Sources:
Hampel FC, Ratner PH, Van Bavel J, et al. Makafi guda biyu, Bincike mai sarrafawa na Azelastine da Fluticasone a cikin Na'urar Na'urar Na'urar Ƙasa Na Nasa. Ann Allergy Asthma Immunol. 2010; 105: 168-173.
Ratner PH, Hampel F, Van Bavel J et al. Haɗin Jiki tare da Azelastine Hydrochloride Nasal Spray da Fluticasone Tsarin Nasa Masu Cinwanci a Cikin Kula da marasa lafiya da Rhinitis na Lafiya. Ann Allergy Asthma Immunol. 2008; 100: 74-81.